播散性肿瘤细胞预测早期乳腺癌区域淋巴结照射疗效
这项前瞻性队列纳入620例局限期乳腺癌患者,在任何原发治疗前从髂嵴骨髓样本检测播散性肿瘤细胞(DTC),94例(15.2%)为DTC阳性。中位随访11.7年后,DTC检测与更高的局部区域复发风险相关(Cox风险比3.26,95%CI 1.6-5.7,P=.001)。多变量亚组分析中,在内乳淋巴结/锁骨上及锁骨下淋巴结(IMN/SCN)照射的DTC阳性患者较DTC阴性患者局部区域复发显著降低(交互检验风险比0.3,95%CI 0.1-0.9,P=.02)。
要点
- 620例局限期乳腺癌中94例(15.2%)DTC阳性,中位随访11.7年47例(7.6%)出现局部区域复发。
- DTC检测与局部区域复发风险升高相关:Cox风险比3.26(95%CI 1.6-5.7,P=.001)。
- IMN/SCN照射在DTC阳性患者中较DTC阴性患者显著降低局部区域复发(交互检验风险比0.3,95%CI 0.1-0.9,P=.02)。
核心结论
- 这项长期分析确认DTC状态对早期乳腺癌区域放疗在局部区域复发方面的疗效具有预测作用。
- 作者认为,经进一步研究后,DTC状态可作为决策工具,以更好地个体化制定早期乳腺癌患者的辅助放疗。
研究设计与样本
- 前瞻性队列研究,纳入620例局限期乳腺癌患者。
- 在任何原发治疗前采集髂嵴骨髓样本检测DTC,由病理学家前瞻性评估DTC状态。
- 照射体积按标准治疗定义,采用Cox和Fine-Gray模型计算累积发生率和风险比,并在多变量分析中行交互检验以确认DTC状态的预测价值。
主要发现
- 620例中94例(15.2%)为DTC阳性;中位随访11.7年后47例(7.6%)出现局部区域复发。
- 单变量和多变量分析中DTC检测与更高的局部区域复发风险相关(Cox风险比3.26,95%CI 1.6-5.7,P=.001)。
- 多变量亚组分析中,IMN/SCN照射在DTC阳性患者中较DTC阴性患者显著降低局部区域复发(交互检验风险比0.3,95%CI 0.1-0.9,P=.02)。
- IMN/SCN是按DTC状态分组后唯一对局部区域复发有影响的照射体积,且DTC状态对局部区域照射获益的预测价值独立于局部区域淋巴结状态。
临床怎么用
- 作者认为,经进一步研究后,DTC状态可作为决策工具,以更好地个体化制定早期乳腺癌患者的辅助放疗。
局限性
- 作者结论提出需进一步研究(After further studies)后DTC状态才可能用作决策工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Disseminated tumor cells (DTCs) collect in the bone marrow and indicate micrometastatic spread. We previously reported that DTCs could be a predictive factor for the efficacy of regional node irradiation (internal mammary nodes [IMNs]/supra- and infraclavicular nodes [SCNs]). In this article, we report the long-term results (>10 years) on the impact of DTC status in early stage breast cancer. METHODS AND MATERIALS: Patients with localized breast cancer were eligible for inclusion in this prospective cohort. DTCs were obtained from a medullary iliac crest sample performed before any primary therapy. DTC status was prospectively assessed by pathologists. Irradiation volumes were defined per standard of care. Cumulative incidence rates and hazard ratios were obtained using both Cox and Fine-Gray models. Interaction tests were performed to confirm the predictive value of DTC status in a multivariate analysis. RESULTS: Six hundred twenty patients with localized breast cancer were included. Overall, 94 patients (15.2%) were DTC-positive. After a median follow-up of 11.7 years, 47 patients (7.6%) experienced locoregional relapse. DTC detection was associated with a higher risk of locoregional relapse in univariate and multivariate analyses (Cox hazard ratio, 3.26; 95% confidence interval, 1.6-5.7; P = .001). In the multivariate subgroup analysis, IMN/SCN irradiation significantly reduced locoregional relapse among DTC-positive patients compared with DTC-negative patients (interaction test: hazard ratio, 0.3; 95% confidence interval, 0.1-0.9; P = .02). IMN/SCN was the only irradiation volume with an impact on locoregional relapse in patients according to DTC status, and the predictive value of DTC status for the benefit of locoregional irradiation was independent of locoregional nodal status. CONCLUSIONS: This long-term analysis confirms the predictive impact of DTC status on the efficacy of regional radiation therapy for locoregional relapse in early breast cancer. After further studies, DTC status could be used as a decision tool to better tailor adjuvant radiation therapy in patients with early stage breast cancer.
引用
- Mignot F, Loirat D, Dureau S, et al. Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 30291993. doi:10.1016/j.ijrobp.2018.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。